Premium
The insecticidal activity and action mode of an imidacloprid analogue, 1‐(3‐pyridylmethyl)‐2‐nitroimino‐imidazolidine
Author(s) -
Zhuang AnXiang,
Zhang YiXi,
Zhang Hui,
Liu ZeWen
Publication year - 2016
Publication title -
insect science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.991
H-Index - 45
eISSN - 1744-7917
pISSN - 1672-9609
DOI - 10.1111/1744-7917.12217
Subject(s) - imidacloprid , agonist , acetylcholine receptor , xenopus , biology , pharmacology , cross resistance , receptor , biochemistry , pesticide , microbiology and biotechnology , gene , agronomy
Neonicotinoids, such as imidacloprid, are key insecticides extensively used for control of Nilaparvata lugens . However, imidacloprid resistance has been reported in many Asian countries in recent years. To understand the roles of the chlorine atom of pyridyl group on insecticidal activity and resistance, the atom was removed to generate an imidacloprid analogue DC‐Imi (DesChlorine Imidacloprid). DC‐Imi showed significantly higher toxicity than imidacloprid in the susceptible strain of N. lugens , but had medium level cross‐resistance in an imidacloprid‐resistant strain. In Xenopus oocyte expressed nicotinic acetylcholine receptors (nAChRs) Nlα1/rβ2, the inward currents evoked by DC‐Imi were detected and could be blocked by typical nAChRs antagonist dihydro‐β‐erythroidine (DHβE), which demonstrated that DC‐Imi acted as an agonist on insect nAChRs. The efficacy of DC‐Imi on Nlα1/rβ2 was 1.8‐fold higher than that of imidacloprid. In addition, the influence of an imidacloprid resistance associated mutation (Y151S) on agonist potencies was evaluated. Compared with the wild‐type receptor, the mutation reduced maximal inward current of DC‐Imi to 55.6% and increased half maximal effective concentration ( EC 50 ) to 3.53‐fold. Compared with imidacloprid (increasing EC 50 to 2.38‐fold of wild‐type receptor), Y151S mutation decreased DC‐Imi potency more significantly. The results indicated that the selective and possibly high toxicities could be achieved through the modification of 6‐chloro‐3‐pyridyl group in imidacloprid and other neonicotinoids.